Bladder dysfunction can cause some of the most distressing symptoms in multiple sclerosis (MS) . Unpredictable urgency combined with poor mobility has a highly adverse effect on any patient's morale and ability to function in society. Fortunately, the symptoms are not an indication of sinister urological disease and upper tract complications and renal failure in MS'-3 is extremely uncommon.
The neural control of the bladder is complex and requires the coordinated action of the autonomic and somatic nervous systems.
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Neural pathways which modulate bladder function traverse the length of the spinal cord between the pons and the sacral spinal cord and are particularly vulnerable in diseases which affect the cord. An area in the dorsal tegmentum of the pons is thought to act upon a spino-bulbo-spinal pathway and "switch" between the storage and voiding phases of micturition.4 Higher centres, especially the medial frontal lobes, influence the pontine micturition centre mainly in an inhibitory manner. 5 As the pathways which control bladder behaviour extend throughout the central nervous system, physiological control is likely to be affected by a disease characterised by disseminated lesions.
The high incidence of bladder dysfunction in MS was first recognised by Oppenheim.6 Several series since have reported an incidence of urinary symptoms in approximately 75% of all patients with MS.7-'2
The commonest symptom is urgency of micturition, which occurs in 24-86% of all those with bladder dysfunction8 10 11 [13] [14] [15] [16] [17] [18] (see  table 1 ). Urinary frequency has been reported in slightly fewer patients, the incidence varying between 17-65%'1 17 and urge incontinence between 34-72% of patients with bladder dysfunction.817
The term "retention" has been applied to both difficulty with and hesitancy of micturition and consequently the incidence of complete urinary retention is unclear. From the data available, however, it seems that a complete failure to void in MS is unusual." 15 Hesitancy of micturition is common and has been reported between 25%'5 and 49% of patients,'3 and is more common in male patients." 14 Formerly the diagnosis of MS could only be established several years after the onset of the first neurological symptoms, and therefore, data or urinary symptoms in the early stages of the disease has depended largely upon patient recall and may thus be question- Urinary symptoms and the neurologicalfeatures of bladder dysfunction in multiple sclerosis Figure 2 shows the patients' pyramidal and bladder function scores. There was an obvious association between the degree of pyramidal tract dysfunction and the severity of the urinary symptoms. Few patients had marked urinary symptoms and low pyramidal scores.
An apparent relationship was also found between the expanded Kurtzke disability status score (EDSS)32 and the severity of the bladder dysfunction, which is to be expected as the EDSS depends largely on the degree of pyramidal dysfunction in the lower limbs. Most patients in the series who were wheelchair dependent (EDSS score > 6&5) had reported at least one episode of urge incontinence.
An internuclear opthalmoplegia (INO) was found in 16 patients but in 14 of these there were, in addition, signs of pyramidal tract disease. In 2, however, there were no pyramidal features, suggesting that a pontine lesion might be responsible for both their bladder and eye movement disorder. Both these patients appear as exceptions in the apparently linear relationship between pyramidal and bladder dysfunction, shown in fig 2. A total of 107 (63%) patients had postmicturition residual volumes greater than 100 mls and their mean residual volume was 220 mls (range 100-700 mls). An important observation was that only 47% of the patients with a significantly raised residual volume actually had sensations of incomplete bladder emptying. However, 83% of the patients who thought their bladder emptying was incomplete, had residual volumes of more than 100 mls.
Filling cystometry showed hyperreflexia in 63 patients (91% of those in whom urodynamics were carried out). The remaining 7 had normal detrusor activity. No patient had detrusor areflexia. Of those patients with normal detrusor activity, 3 had pyramidal function scores of 2, and 3 had scores of 1. Of the 2 patients with zero pyramidal scores, 1 was I micturition centre was a significant factor.
The commonest urinary symptoms were irritative in nature (that is, urgency, frequency and urge incontinence) and difficulty in initiating voluntary voiding was a concurrent symptom in approximately half of the patients. Patients with more advanced bladder dysfunction became unable to void voluntarily and could empty only when they experienced spontaneous hyperreflexic detrusor contractions.
The recognition of incomplete bladder emptying is important since anticholinergic medication given for hyperreflexia may be ineffective if the residual volume is large. Symptoms of retention provide some guide to the likelihood of incomplete bladder emptying but were found not to be sufficiently reliable to exclude the problem. Measurement of the post-micturition residual volume is therefore an essential part of the assessment of a patient with MS who has urinary symptoms. More than half of the patients were found to have significant residual volumes and this has important therapeutic implications in patients with MS.
The commonest urodynamic finding was detrusor hyperreflexia and the results indicate that MS patients with irritative bladder symptoms and lower limb pyramidal involvement are highly likely to have detrusor hyperreflexia.
The explanation of detrusor areflexia in MS remains uncertain. Several investigators have reported that in some patients with MS the initial urodynamic tests showed detrusor areflexia but subsequent studies demonstrated hyperreflexia.'62"1837 The neurological basis for this complete change in detrusor activity remains obscure.
Of particular importance in the modern concept of the neural control of the bladder are long loop reflexes via the pontine tegmentum.4 Interruption of pathways between the sacral cord and pons may result in detrusor hyperreflexia and loss of the coordinated action of the detrusor and the external striated urethral sphincter during voiding, a condition known as detrusor sphincter dyssynergia (DSD).38 The Although we have not specifically addressed the question of treatment, the two main disorders which arise in MS patients with urinary symptoms are detrusor hyperreflexia and incomplete emptying. The postmicturition residual volume cannot be predicted from the urinary symptoms but is easily measured by catheterisation or ultrasound. The majority of MS patients with bladder dysfunction are managed by non-surgical means; anticholinergics to control hyperreflexia and intermittent catheterisation if there is a significant post-micturition residual volume. Thus in a patient with MS and symptoms of bladder dysfunction who has pyramidal signs in the lower limbs, detrusor hyperreflexia with a variable degree of incomplete emptying can be anticipated and appropriate treatment instituted after measuring the post-micturition residual volume.
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